News

Video

Long-Term Data for Frontline Nivolumab Plus Chemo or Ipilimumab in Advanced ESCC

Samuel Cytryn, MD, and David B. Zhen, MD, on long-term data for nivolumab plus chemotherapy or ipilimumab in advanced esophageal squamous cell carcinoma.

Video Player is loading.
Current Time 0:00
Duration 3:07
Loaded: 0%
Stream Type LIVE
Remaining Time 3:07
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
  • en (Main), selected